Wall Street Experts
ver. ZuMIgo(08/25)
SMS Pharmaceuticals Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 7 685
EBIT TTM (mln): 1 005
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
Rok finansowy |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
1,187 |
1,230 |
1,686 |
2,104 |
2,448 |
2,198 |
2,259 |
2,141 |
2,452 |
5,180 |
5,793 |
6,032 |
4,356 |
4,605 |
4,618 |
4,073 |
5,608 |
5,150 |
5,197 |
7,093 |
Przychód Δ r/r |
0.0% |
3.7% |
37.0% |
24.8% |
16.3% |
-10.2% |
2.8% |
-5.2% |
14.5% |
111.3% |
11.8% |
4.1% |
-27.8% |
5.7% |
0.3% |
-11.8% |
37.7% |
-8.2% |
0.9% |
36.5% |
Marża brutto |
29.8% |
33.9% |
33.6% |
29.7% |
21.6% |
23.0% |
33.4% |
44.1% |
18.7% |
29.0% |
33.5% |
35.4% |
25.6% |
29.6% |
29.1% |
31.3% |
32.4% |
35.2% |
24.1% |
29.7% |
EBIT (mln) |
210 |
255 |
473 |
524 |
352 |
316 |
267 |
72 |
-1,511 |
444 |
837 |
203 |
534 |
722 |
681 |
539 |
977 |
790 |
213 |
1,340 |
EBIT Δ r/r |
0.0% |
21.5% |
85.5% |
10.6% |
-32.9% |
-10.0% |
-15.7% |
-72.9% |
-2187.9% |
-129.4% |
88.7% |
-75.7% |
162.6% |
35.2% |
-5.6% |
-20.8% |
81.1% |
-19.1% |
-73.0% |
528.0% |
EBIT (%) |
17.7% |
20.7% |
28.1% |
24.9% |
14.4% |
14.4% |
11.8% |
3.4% |
-61.6% |
8.6% |
14.5% |
3.4% |
12.3% |
15.7% |
14.8% |
13.2% |
17.4% |
15.3% |
4.1% |
18.9% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
179 |
0 |
2 |
124 |
163 |
156 |
152 |
148 |
114 |
112 |
103 |
182 |
210 |
235 |
EBITDA (mln) |
245 |
296 |
515 |
575 |
414 |
400 |
393 |
199 |
-1,374 |
572 |
1,009 |
918 |
760 |
951 |
930 |
841 |
1,237 |
1,188 |
585 |
1,211 |
EBITDA(%) |
20.7% |
24.0% |
30.6% |
27.3% |
16.9% |
18.2% |
17.4% |
9.3% |
-56.0% |
11.0% |
17.4% |
15.2% |
17.5% |
20.6% |
20.1% |
20.6% |
22.1% |
23.1% |
11.3% |
17.1% |
Podatek (mln) |
33 |
46 |
117 |
52 |
16 |
5 |
21 |
3 |
43 |
116 |
322 |
146 |
60 |
199 |
209 |
181 |
302 |
6 |
15 |
169 |
Zysk Netto (mln) |
84 |
85 |
210 |
272 |
63 |
24 |
84 |
11 |
253 |
204 |
352 |
409 |
285 |
317 |
400 |
316 |
625 |
622 |
-71 |
498 |
Zysk netto Δ r/r |
0.0% |
0.7% |
146.5% |
29.5% |
-76.8% |
-62.0% |
250.4% |
-86.4% |
2126.4% |
-19.5% |
72.9% |
16.0% |
-30.3% |
11.5% |
26.1% |
-21.2% |
98.0% |
-0.5% |
-111.3% |
-805.8% |
Zysk netto (%) |
7.1% |
6.9% |
12.4% |
12.9% |
2.6% |
1.1% |
3.7% |
0.5% |
10.3% |
3.9% |
6.1% |
6.8% |
6.5% |
6.9% |
8.7% |
7.8% |
11.1% |
12.1% |
-1.4% |
7.0% |
EPS |
2.06 |
2.08 |
2.95 |
2.72 |
0.63 |
0.24 |
0.84 |
0.11 |
2.53 |
2.31 |
4.16 |
4.83 |
3.37 |
3.75 |
4.73 |
3.73 |
7.39 |
7.35 |
-0.83 |
5.89 |
EPS (rozwodnione) |
2.06 |
2.08 |
2.95 |
2.72 |
0.63 |
0.24 |
0.84 |
0.11 |
2.53 |
2.31 |
4.16 |
4.83 |
3.37 |
3.75 |
4.73 |
3.73 |
7.39 |
7.35 |
-0.83 |
5.89 |
Ilośc akcji (mln) |
41 |
41 |
71 |
100 |
100 |
100 |
100 |
100 |
100 |
88 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
Ważona ilośc akcji (mln) |
41 |
41 |
71 |
100 |
100 |
100 |
100 |
100 |
100 |
88 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
85 |
Waluta |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |